BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 12124405)

  • 21. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
    Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk and predictors of mortality associated with chronic hepatitis B infection.
    Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC; Lewis D; Dyke T; Alpers MP
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.
    Sun HC; Zhang W; Qin LX; Zhang BH; Ye QH; Wang L; Ren N; Zhuang PY; Zhu XD; Fan J; Tang ZY
    J Hepatol; 2007 Nov; 47(5):684-90. PubMed ID: 17854945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
    Tseng TC; Liu CJ; Chen CL; Yang HC; Su TH; Wang CC; Yang WT; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2013 Aug; 208(4):584-93. PubMed ID: 23656977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
    Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
    Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.
    Yuen MF; Wong DK; Sablon E; Tse E; Ng IO; Yuan HJ; Siu CW; Sander TJ; Bourne EJ; Hall JG; Condreay LD; Lai CL
    Hepatology; 2004 Jun; 39(6):1694-701. PubMed ID: 15185311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
    Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
    Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.
    Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ
    J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
    Livingston SE; Simonetti JP; Bulkow LR; Homan CE; Snowball MM; Cagle HH; Negus SE; McMahon BJ
    Gastroenterology; 2007 Nov; 133(5):1452-7. PubMed ID: 17920063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative roles of HBsAg seroclearance and mortality in the decline of HBsAg prevalence with increasing age.
    Tai DI; Tsay PK; Chen WT; Chu CM; Liaw YF
    Am J Gastroenterol; 2010 May; 105(5):1102-9. PubMed ID: 20197760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of gender, viral transmission and aging in the prevalence of hepatitis B surface antigen.
    Tsay PK; Tai DI; Chen YM; Yu CP; Wan SY; Shen YJ; Lin DY
    Chang Gung Med J; 2009; 32(2):155-64. PubMed ID: 19403005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
    Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load.
    Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
    Hepatology; 2012 Jan; 55(1):68-76. PubMed ID: 21858846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.